Bifidobacterium in the treatment of inflammatory disease

  • Collins J
  • O'Sullivan G
  • O'Mahony L
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.

Cite

CITATION STYLE

APA

Collins, J. K., O’Sullivan, G. C., O’Mahony, L., & Shanahan, F. (2007). Bifidobacterium in the treatment of inflammatory disease. United States Patent, 2(12).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free